Cite
MLA Citation
Stephen Norris et al.. “Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.” British journal of clinical pharmacology, vol. 83, 2017, pp. 1815–1825. http://access.bl.uk/ark:/81055/vdc_100047807172.0x000023